Sandoz Telmisartan Hct 12.5 mg (Hydrochlorothiazide TABLET) 12.5 MG

Sandoz Telmisartan HCT 12.5 mg combines telmisartan and hydrochlorothiazide for blood pressure management. This oral tablet is designed to support cardiovascular health by promoting blood vessel relaxation and fluid balance.

Strength

12.5 MG

Pack Size

30/100

Manufacturer / TM Owner

SANDOZ CANADA INCORPORATED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Sandoz Telmisartan HCT 12.5 mg is commonly used for managing high blood pressure. The combination of telmisartan, an angiotensin II receptor blocker, and hydrochlorothiazide, a diuretic, works to lower blood pressure by relaxing blood vessels and reducing fluid retention. This medication is often prescribed for individuals who require dual-action therapy to achieve optimal blood pressure control.

Side Effects

Common effects of Sandoz Telmisartan HCT 12.5 mg may include dizziness, headache, and fatigue. Some users might experience dry mouth or mild gastrointestinal discomfort. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Precautions & Warnings

Handle Sandoz Telmisartan HCT 12.5 mg with care, especially if you have kidney or liver issues. Regular monitoring of blood pressure and electrolyte levels is recommended. Avoid sudden changes in dosage without consulting a healthcare professional.

Avoid Interactions

Sandoz Telmisartan HCT 12.5 mg may interact with certain medications, including other blood pressure drugs, NSAIDs, and lithium. Alcohol consumption should be moderated, as it can enhance the medication's effects. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

Sandoz Telmisartan HCT 12.5 mg is used to manage high blood pressure by combining telmisartan and hydrochlorothiazide for dual-action therapy.

Sandoz Telmisartan HCT 12.5 mg is taken orally, typically once daily, as directed by a healthcare provider.

Common side effects may include dizziness, headache, fatigue, dry mouth, and mild gastrointestinal discomfort.

Alcohol should be moderated while taking Sandoz Telmisartan HCT 12.5 mg, as it can enhance the medication's effects.

Individuals with severe kidney or liver issues should use Sandoz Telmisartan HCT 12.5 mg with caution and under medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.